Repurposing medications for treatment of age-related macular degeneration: Insights from novel approaches to data mining
J Moir, S Aggarwal, D Skondra - Experimental Biology and …, 2023 - journals.sagepub.com
The economic and visual burdens associated with age-related macular degeneration (AMD)
are expected to significantly increase in the coming years. As of now, interventions to delay …
are expected to significantly increase in the coming years. As of now, interventions to delay …
Associations between systemic medications and development of wet age‐related macular degeneration
Purpose To examine whether systemic medications are associated with the subsequent
development of wet age‐related macular degeneration (AMD). Methods A retrospective …
development of wet age‐related macular degeneration (AMD). Methods A retrospective …
Systemic medication use and the incidence and growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials
Purpose: To determine associations of systemic medications with the incidence and growth
of geographic atrophy (GA) in participants of the comparison of age-related macular …
of geographic atrophy (GA) in participants of the comparison of age-related macular …
SGLT‐2 Inhibitor Use and Cause‐Specific Hospitalization Rates: An Outcome‐Wide Study to Identify Novel Associations of SGLT‐2 Inhibitors
Sodium‐glucose co‐transporter 2 inhibitors (SGLT2is) have demonstrated multifaceted
pharmacological effects. In addition to type 2 diabetes, they are now indicated for heart …
pharmacological effects. In addition to type 2 diabetes, they are now indicated for heart …